Boston licenses Mentor incontinence technology:
This article was originally published in Clinica
Boston Scientific has nonexclusively licensed technology owned by Mentor to treat female urinary incontinence. The agreement comes some seven months after Mentor obtained a US patent covering its transobturator subfascial sling technique, which is designed to reduce the risk of major bleeding or bowel or bladder injury compared with other tension-free vaginal tape procedures. Following the issuance of the patent, Mentor filed suit against American Medical Systems alleging infringement. Mentor markets a stress incontinence product, ObTape, based on the technology.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.